Infrared light therapy for Crohn's disease
Part of Digestive system clinical trials.
This trial tests a new infrared light treatment to see if it can reduce inflammation and symptoms in people with Crohn's disease. It's for those who have active disease despite current treatments or who are not on therapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed diagnosis of Crohn's disease.
- You are between 18 and 80 years old.
- You have active Crohn's symptoms (like stomach pain, diarrhea) or a high level of inflammation in your stool (calprotectin > 150).
- You are not on any Crohn's treatment, or you have been on a stable dose of your current medicine for at least the required time (e.g., 6 weeks for mesalamine, 2 weeks for steroids or cannabis, 12 weeks for immunomodulators or biologics).
- Your body mass index (BMI) must be under 30, and you must not have a current infection, pregnancy, serious chronic illness (like cancer, organ failure), or certain complications (like abscesses or fistulas).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a special diet using a nutritional supplement can reduce inflammation and improve symptoms in people with active Crohn's disease affecting the small intestine. It aims to see how the diet changes gut bacteria and body composition.
This study checks whether adding an extra, cross-body “transmural” evaluation (looking at inflammation throughout the bowel) improves care for adults with Crohn’s who are starting or receiving biologic (biotherapy) treatment. It uses close follow-up with stool calprotectin (a marker of gut inflammation) to see if this approach helps control inflammation.
This trial tests a low dose of IL-2 to reduce inflammation and help control Crohn’s disease symptoms. It’s for people whose Crohn’s disease hasn’t responded to at least one standard treatment or who need steroids to stay under control.
This trial tests whether a specific set of abdominal exercises can help reduce inflammation and improve symptoms in people with Crohn's disease. You'll do the exercises at home daily, and the study will track your results over time to see if it's a helpful addition to your usual care.
This trial studies whether daily bright light can improve gut barrier “leakiness” and reduce inflammation in adults with Crohn’s disease or ulcerative colitis. It compares bright light versus dim light in a crossover design, meaning you may receive both.
This study tests whether morning light therapy can help reduce inflammation in people with ulcerative colitis. It may be an option if you have active inflammation and can attend light sessions.
Hear when a new IBD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.